Stocks Immunovant Receives Patent for Antibodies Against Autoimmune Diseases From Investing.comMarch 12, 2024 NEW YORK – Immunovant, Inc. (NASDAQ:), a clinical-stage immunology company, has been awarded a U.S.…
Stocks VenoValve Trial Shows Promise for Treatment of Venous Diseases By Investing.comMarch 6, 2024 IRVINE, Calif. – enVVeno Medical Corporation (NASDAQ:NVNO), a medical device company, reported positive efficacy data…